Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of a Step-wise Protocol in Optimizing CCH Outcomes in Men With Peyronie's Disease
NCT06649539Phase 4Active, not recruiting
- Sponsor
- Charitable Union for the Research and Education of Peyronie's Disease
- Start
- Oct 2024
- Primary completion
- Oct 2029
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Charitable Union for the Research and Education of Peyronie's Disease. Started Oct 2024; status: active, not recruiting.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT06649539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06649539.